A Prospective, One-arm and Open Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia
Clinical trial NCT05694767 · COMPLETED
Trial details
- NCT number
- NCT05694767
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-22
- Primary completion
- 2023-12-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.